Market closed
Bone Biologics Corp/$BBLG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bone Biologics Corp
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Ticker
$BBLG
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
2
ISIN
US0980705018
Website
BBLG Metrics
BasicAdvanced
$2.3M
-
-$4.83
0.93
-
Price and volume
Market cap
$2.3M
Beta
0.93
52-week high
$1.00
52-week low
$0.57
Average daily volume
40K
Financial strength
Current ratio
10.223
Quick ratio
8.803
Management effectiveness
Return on assets (TTM)
-69.40%
Return on equity (TTM)
-128.71%
Valuation
Price to book
0.59
Price to tangible book (TTM)
0.59
Price to free cash flow (TTM)
-0.254
Growth
Earnings per share change (TTM)
-85.80%
3-year earnings per share growth (CAGR)
-49.44%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bone Biologics Corp stock?
Bone Biologics Corp (BBLG) has a market cap of $2.3M as of May 09, 2025.
What is the P/E ratio for Bone Biologics Corp stock?
The price to earnings (P/E) ratio for Bone Biologics Corp (BBLG) stock is 0 as of May 09, 2025.
Does Bone Biologics Corp stock pay dividends?
No, Bone Biologics Corp (BBLG) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Bone Biologics Corp dividend payment date?
Bone Biologics Corp (BBLG) stock does not pay dividends to its shareholders.
What is the beta indicator for Bone Biologics Corp?
Bone Biologics Corp (BBLG) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.